Dr. Jerome Potozkin, MD

Dr. Potozkin practices at Jerome R Potozkin MD, a Professional Corporation in Danville, California.

Dr. Potozkin's NPI, 1184635195, was assigned on August 11, 2006. Dr. Potozkin graduated from New York University School of Medicine in 1988. Dr. Potozkin's California license number on file is G73505.

Dr. Potozkin's primary practice is Jerome R Potozkin MD, a Professional Corporation, at 600 San Ramon Valley Blvd, Danville, CA 94526 in Contra Costa County. The practice phone is (925) 385-8980.

Dr. Potozkin's primary practice is Jerome R Potozkin MD, a Professional Corporation in Danville, California. The medical group on file is Potozkin + Ellis Dermatology. Dmand AI also links Dr. Potozkin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Potozkin practices. Vendor and product names are available with a free account.

Dermatology is Dr. Potozkin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Potozkin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Potozkin's licenses on file in 2 states: California and New York.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes, joint cyst and minor head injury among the conditions Dr. Potozkin treats.

CMS data shows 3,965 Medicare services from Dr. Potozkin across 20 procedure codes in 2024, for 686 Medicare patients. Medicare paid $357,954 for them. Every service was in an office.

CMS counts 686 Medicare patients who saw Dr. Potozkin in 2024. The largest group is 75 to 84, with 291 patients. 75% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Potozkin's median patient age at 61, with 52% women.

In 2024, Dr. Potozkin wrote 581 Medicare Part D claims for 226 patients. 99% of them were for generic drugs. CMS names the drug for 538 of them, across 17 drugs with 11 or more claims each, at $13,476 in total drug cost. In 2023, CMS named 569 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Potozkin for performance year 2024, reported as part of a group. Dr. Potozkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 726 procedures of removal of skin lesions by Dr. Potozkin, more than 90% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Potozkin. Dr. Potozkin's most frequent co-author is Roy G. Geronemus, MD.

CMS Open Payments shows 210 general payments to Dr. Potozkin from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 44% of the total. Allergan Inc. paid the most, $7,670.

Dmand AI lists 3 awards for Dr. Potozkin.

Dr. Potozkin graduated from New York University School of Medicine in 1988. Dr. Potozkin is a member of AAD and ASDS.

Dr. Potozkin is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.